ALOÑA
AGIRRE LIZASO
![Foto de ALOÑA](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (7)
2024
-
Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma
Hepatology, Vol. 79, Núm. 4, pp. 941-958
-
m6A Methylated Long Noncoding RNA LOC339803 Regulates Intestinal Inflammatory Response
Advanced Science, Vol. 11, Núm. 13
2023
-
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 709-726
-
Inhibition of YTHDF1 by salvianolic acid overcomes gluten-induced intestinal inflammation
Gut
-
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
Cancers, Vol. 15, Núm. 20
2022
-
TREM-2 plays a protective role in cholestasis by acting as a negative regulator of inflammation
Journal of Hepatology, Vol. 77, Núm. 4, pp. 991-1004
2021
-
Pathogenesis of Cholangiocarcinoma
Annual Review of Pathology: Mechanisms of Disease, Vol. 16, pp. 433-463